Abstract
Introduction/Background The COVID-19 pandemic has disrupted major aspects of daily life since its emergence in late 2019, impacting health and well-being worldwide. Aside from genetic predisposition, numerous external factors play key roles in determining levels of disease susceptibility and overall health status.
Aim/Objectives This review and policy analysis sought to examine literature focused on the impact of neighborhood environments on population health and well-being during the COVID-19 pandemic period. Examined studies explore the impacts of various aspects of the neighborhood environment (i.e., walkability, transportation, access to healthcare/vaccination, etc.) during the COVID-19 era on population health and well-being.
Methods Databases were searched for studies published from March 2020 to August 2022. Selected studies examine the impacts of various aspects of the neighborhood environment (i.e., walkability, transportation, access to healthcare/vaccination, climate, crime rates, persistent poverty, the social spread of misinformation, etc.) during the COVID-19 era on population health and well-being.
Results Findings from our review suggest that those living in less-than-favorable environments were faced with significant challenges, making vulnerable populations more prone to the severity of COVID-19 infection.
Conclusion We argue these results establish cause for the consideration of the effects of neighborhood environments in developing intelligent intervention strategies for both pandemic recovery and preparation for future public health emergencies, especially among vulnerable populations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is partially supported by Grant# 1R37CA234119-01A1 from National Cancer Institute (NCI).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos